Photoditazine mediated chemosensitized blood photomodification: advanced tumor treatment preliminary results

M. L. Gelfond; D. V. Vassiliev

doi:10.1117/12.640216

7 December 2006 Photoditazine mediated chemosensitized blood photomodification: advanced tumor treatment preliminary results

M. L. Gelfond, D. V. Vassiliev

Author Affiliations +

Proceedings Volume 5973, Current Research on Laser Use in Oncology: 2000-2004; 59730X (2006) https://doi.org/10.1117/12.640216
Event: Current Research on Laser Use in Oncology: 2000-2004, 2004, Moscow, Russian Federation

Abstract

Beside the classical photodynamic therapy (PDT) procedure, another possible mode of PDT treatment exists. In the latter case the light does not have to be delivered directly to tumor as soon as it is not always technically possible. In some cases systemic cytotoxic effects of photomodified blood can cause tumor damage. Possibly this happens due to apoptosis induction. These observations broaden possible PDT applications significantly.

Citation Download Citation

M. L. Gelfond and D. V. Vassiliev "Photoditazine mediated chemosensitized blood photomodification: advanced tumor treatment preliminary results", Proc. SPIE 5973, Current Research on Laser Use in Oncology: 2000-2004, 59730X (7 December 2006); https://doi.org/10.1117/12.640216

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available